ICAD Inc
NASDAQ:ICAD

Watchlist Manager
ICAD Inc Logo
ICAD Inc
NASDAQ:ICAD
Watchlist
Price: 2.4 USD 13.74% Market Closed
Market Cap: 63.7m USD
Have any thoughts about
ICAD Inc?
Write Note

Intrinsic Value

ICAD's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ICAD stock under the Base Case scenario is 2.05 USD. Compared to the current market price of 2.4 USD, ICAD Inc is Overvalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ICAD Intrinsic Value
2.05 USD
Overvaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
ICAD Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ICAD cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ICAD?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about ICAD Inc

Provide an overview of the primary business activities
of ICAD Inc.

What unique competitive advantages
does ICAD Inc hold over its rivals?

What risks and challenges
does ICAD Inc face in the near future?

Has there been any significant insider trading activity
in ICAD Inc recently?

Summarize the latest earnings call
of ICAD Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ICAD Inc.

Provide P/S
for ICAD Inc.

Provide P/E
for ICAD Inc.

Provide P/OCF
for ICAD Inc.

Provide P/FCFE
for ICAD Inc.

Provide P/B
for ICAD Inc.

Provide EV/S
for ICAD Inc.

Provide EV/GP
for ICAD Inc.

Provide EV/EBITDA
for ICAD Inc.

Provide EV/EBIT
for ICAD Inc.

Provide EV/OCF
for ICAD Inc.

Provide EV/FCFF
for ICAD Inc.

Provide EV/IC
for ICAD Inc.

Show me price targets
for ICAD Inc made by professional analysts.

What are the Revenue projections
for ICAD Inc?

How accurate were the past Revenue estimates
for ICAD Inc?

What are the Net Income projections
for ICAD Inc?

How accurate were the past Net Income estimates
for ICAD Inc?

What are the EPS projections
for ICAD Inc?

How accurate were the past EPS estimates
for ICAD Inc?

What are the EBIT projections
for ICAD Inc?

How accurate were the past EBIT estimates
for ICAD Inc?

Compare the revenue forecasts
for ICAD Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ICAD Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ICAD Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of ICAD Inc compared to its peers.

Compare the P/E ratios
of ICAD Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing ICAD Inc with its peers.

Analyze the financial leverage
of ICAD Inc compared to its main competitors.

Show all profitability ratios
for ICAD Inc.

Provide ROE
for ICAD Inc.

Provide ROA
for ICAD Inc.

Provide ROIC
for ICAD Inc.

Provide ROCE
for ICAD Inc.

Provide Gross Margin
for ICAD Inc.

Provide Operating Margin
for ICAD Inc.

Provide Net Margin
for ICAD Inc.

Provide FCF Margin
for ICAD Inc.

Show all solvency ratios
for ICAD Inc.

Provide D/E Ratio
for ICAD Inc.

Provide D/A Ratio
for ICAD Inc.

Provide Interest Coverage Ratio
for ICAD Inc.

Provide Altman Z-Score Ratio
for ICAD Inc.

Provide Quick Ratio
for ICAD Inc.

Provide Current Ratio
for ICAD Inc.

Provide Cash Ratio
for ICAD Inc.

What is the historical Revenue growth
over the last 5 years for ICAD Inc?

What is the historical Net Income growth
over the last 5 years for ICAD Inc?

What is the current Free Cash Flow
of ICAD Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for ICAD Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ICAD Inc

Current Assets 27.8m
Cash & Short-Term Investments 20.4m
Receivables 5.4m
Other Current Assets 2.1m
Non-Current Assets 11.1m
PP&E 2.1m
Intangibles 8.5m
Other Non-Current Assets 579k
Current Liabilities 6.6m
Accounts Payable 501k
Accrued Liabilities 2.7m
Other Current Liabilities 3.3m
Non-Current Liabilities 1.4m
Other Non-Current Liabilities 1.4m
Efficiency

Earnings Waterfall
ICAD Inc

Revenue
18.8m USD
Cost of Revenue
-2.6m USD
Gross Profit
16.2m USD
Operating Expenses
-21.3m USD
Operating Income
-5.1m USD
Other Expenses
2.9m USD
Net Income
-2.3m USD

Free Cash Flow Analysis
ICAD Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

iCAD Inc. reported a 21% increase in Q2 2024 revenue to $5 million. Product revenue soared by 41% to $3.3 million, despite a 5% decline in service revenue. The company's new ProFound Cloud platform has exceeded expectations, securing multiple deals and highlighting the shift towards a SaaS model. As a result, iCAD expects stronger economic returns and greater revenue visibility through recurring revenue models. The company saw its GAAP net loss decrease to $1.7 million from $2.3 million, with a gross profit margin improving to 84%. This growth and transformation are projected to drive enhanced profitability in the long term.

What is Earnings Call?
Fundamental Scores

ICAD Profitability Score
Profitability Due Diligence

ICAD Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Positive Revenue Growth Forecast
ROIC is Increasing
25/100
Profitability
Score

ICAD Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

ICAD Solvency Score
Solvency Due Diligence

ICAD Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
49/100
Solvency
Score

ICAD Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ICAD Price Targets Summary
ICAD Inc

Wall Street analysts forecast ICAD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ICAD is 4.93 USD with a low forecast of 2.53 USD and a high forecast of 9.45 USD.

Lowest
Price Target
2.53 USD
5% Upside
Average
Price Target
4.93 USD
105% Upside
Highest
Price Target
9.45 USD
294% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ICAD?

Click here to dive deeper.

Dividends

ICAD Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ICAD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ICAD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

ICAD News

Other Videos

Profile

ICAD Inc Logo
ICAD Inc

Country

United States of America

Industry

Health Care

Market Cap

63.3m USD

Dividend Yield

0%

Description

iCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions. The company is headquartered in Nashua, New Hampshire and currently employs 136 full-time employees. The firm operates through two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). In the Detection segment, the Company’s solutions include advanced image analysis and workflow solutions enables healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, and a comprehensive range of artificial intelligence and computer aided detection (CAD) systems and workflow solutions for two-dimension(2D) and third dimension (3D) mammography, magnetic resonance imaging (MRI) and computed tomography (CT). In the Therapy segment, the Company offers the Xoft System, an isotope-free cancer treatment platform technology. The Xoft System can be used for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.

Contact

NEW HAMPSHIRE
Nashua
98 Spit Brook Rd Ste 100
+16038825200.0
www.icadmed.com

IPO

1984-12-13

Employees

136

Officers

President, CEO & Executive Chair
Ms. Dana R. Brown
Chief Financial Officer
Mr. Eric Lonnqvist
Chief Technology Officer
Mr. Jonathan Go
Chief Operations Officer
Ms. Michelle Strong
Vice President of Administration
Ms. Annette L. Heroux
Chief People Officer
Brian Testa
Show More
Senior VP of Global Sales Operations
Mr. Bill Keyes
Chief Product Officer
Mr. Vasu Avadhanula
Senior VP of North American Sales
Mr. Peter Graham
Show Less

See Also

Discover More
What is the Intrinsic Value of one ICAD stock?

The intrinsic value of one ICAD stock under the Base Case scenario is 2.05 USD.

Is ICAD stock undervalued or overvalued?

Compared to the current market price of 2.4 USD, ICAD Inc is Overvalued by 15%.

Back to Top